Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Cervarix - July 26 Clinical Comments - August 08, 2007

From: Sullivan, Helen M
To: "";
Subject: RE: Cervarix - July 26 Clinical Comments
Date: Wednesday, August 08, 2007 5:37:25 PM
Please submit updated safety reports until this time. CBER may request additional submissions of safety reports during the course of review of the BLA.

From: [] Sent: Thursday, July 26, 2007 4:33 PM To: Sullivan, Helen M Subject: Re: Cervarix - July 26 Clinical Comments
Hi Helen,
Can we please get the following clarification for Question 2:
Do you want these IND safety reports through Sept 30, 2006 (the BLA cut-off date for HPV-009)?
Thanks, Matt
"Sullivan, Helen M" <>
To 26-Jul-2007 13:32 cc Subject Cervarix - July 26 Clinical Comments
Please find attached additional clinical comments from CBER.
<<07 26 07 EM clinical.pdf>> [attachment "07 26 07 EM clinical.pdf" deleted by Matt Whitman-1/SB-OTHER/PHRD/ SB_PLC]
"EMF <>" made the following annotations.
This message was sent by Glaxo Wellcome across the Internet in encrypted format and was successfully decrypted, unless otherwise noted. Glaxo Wellcome


Page Last Updated: 04/14/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English